179 related articles for article (PubMed ID: 32877837)
1. Leishmania Viannia guyanensis, LRV1 virus and extracellular vesicles: a dangerous trio influencing the faith of immune response during muco-cutaneous leishmaniasis.
Olivier M; Zamboni DS
Curr Opin Immunol; 2020 Oct; 66():108-113. PubMed ID: 32877837
[TBL] [Abstract][Full Text] [Related]
2. Type I interferons induced by endogenous or exogenous viral infections promote metastasis and relapse of leishmaniasis.
Rossi M; Castiglioni P; Hartley MA; Eren RO; Prével F; Desponds C; Utzschneider DT; Zehn D; Cusi MG; Kuhlmann FM; Beverley SM; Ronet C; Fasel N
Proc Natl Acad Sci U S A; 2017 May; 114(19):4987-4992. PubMed ID: 28439019
[TBL] [Abstract][Full Text] [Related]
3. Leishmania RNA virus controls the severity of mucocutaneous leishmaniasis.
Ives A; Ronet C; Prevel F; Ruzzante G; Fuertes-Marraco S; Schutz F; Zangger H; Revaz-Breton M; Lye LF; Hickerson SM; Beverley SM; Acha-Orbea H; Launois P; Fasel N; Masina S
Science; 2011 Feb; 331(6018):775-8. PubMed ID: 21311023
[TBL] [Abstract][Full Text] [Related]
4. Detection of Leishmania RNA Virus 1 in Leishmania (Viannia) panamensis Isolates, Panama.
Gonzalez K; De León SS; Pineda V; Samudio F; Capitan-Barrios Z; Suarez JA; Weeden A; Ortiz B; Rios M; Moreno B; Gundacker ND; Pascale JM; López-Vergès S; Sosa N; Saldaña A; Ábrego LE
Emerg Infect Dis; 2023 Jun; 29(6):1250-1253. PubMed ID: 37209675
[TBL] [Abstract][Full Text] [Related]
5. Presence of Leishmania RNA Virus 1 in Leishmania guyanensis Increases the Risk of First-Line Treatment Failure and Symptomatic Relapse.
Bourreau E; Ginouves M; Prévot G; Hartley MA; Gangneux JP; Robert-Gangneux F; Dufour J; Sainte-Marie D; Bertolotti A; Pratlong F; Martin R; Schütz F; Couppié P; Fasel N; Ronet C
J Infect Dis; 2016 Jan; 213(1):105-11. PubMed ID: 26123564
[TBL] [Abstract][Full Text] [Related]
6. Exacerbated Leishmaniasis Caused by a Viral Endosymbiont can be Prevented by Immunization with Its Viral Capsid.
Castiglioni P; Hartley MA; Rossi M; Prevel F; Desponds C; Utzschneider DT; Eren RO; Zangger H; Brunner L; Collin N; Zehn D; Kuhlmann FM; Beverley SM; Fasel N; Ronet C
PLoS Negl Trop Dis; 2017 Jan; 11(1):e0005240. PubMed ID: 28099431
[TBL] [Abstract][Full Text] [Related]
7. Leishmania (Viannia) guyanensis in tegumentary leishmaniasis.
Borges AF; Gomes RS; Ribeiro-Dias F
Pathog Dis; 2018 Jun; 76(4):. PubMed ID: 29722820
[TBL] [Abstract][Full Text] [Related]
8. Tilting the balance between RNA interference and replication eradicates Leishmania RNA virus 1 and mitigates the inflammatory response.
Brettmann EA; Shaik JS; Zangger H; Lye LF; Kuhlmann FM; Akopyants NS; Oschwald DM; Owens KL; Hickerson SM; Ronet C; Fasel N; Beverley SM
Proc Natl Acad Sci U S A; 2016 Oct; 113(43):11998-12005. PubMed ID: 27790981
[TBL] [Abstract][Full Text] [Related]
9. Mammalian Innate Immune Response to a Leishmania-Resident RNA Virus Increases Macrophage Survival to Promote Parasite Persistence.
Eren RO; Reverte M; Rossi M; Hartley MA; Castiglioni P; Prevel F; Martin R; Desponds C; Lye LF; Drexler SK; Reith W; Beverley SM; Ronet C; Fasel N
Cell Host Microbe; 2016 Sep; 20(3):318-328. PubMed ID: 27593513
[TBL] [Abstract][Full Text] [Related]
10. Muco-cutaneous leishmaniasis in the New World: the ultimate subversion.
Ronet C; Beverley SM; Fasel N
Virulence; 2011; 2(6):547-52. PubMed ID: 21971185
[TBL] [Abstract][Full Text] [Related]
11. Leishmania guyanensis M4147 as a new LRV1-bearing model parasite: Phosphatidate phosphatase 2-like protein controls cell cycle progression and intracellular lipid content.
Zakharova A; Albanaz ATS; Opperdoes FR; Škodová-Sveráková I; Zagirova D; Saura A; Chmelová L; Gerasimov ES; Leštinová T; Bečvář T; Sádlová J; Volf P; Lukeš J; Horváth A; Butenko A; Yurchenko V
PLoS Negl Trop Dis; 2022 Jun; 16(6):e0010510. PubMed ID: 35749562
[TBL] [Abstract][Full Text] [Related]
12. Further Evidence of an Association between the Presence of Leishmania RNA Virus 1 and the Mucosal Manifestations in Tegumentary Leishmaniasis Patients.
Cantanhêde LM; da Silva Júnior CF; Ito MM; Felipin KP; Nicolete R; Salcedo JM; Porrozzi R; Cupolillo E; Ferreira Rde G
PLoS Negl Trop Dis; 2015; 9(9):e0004079. PubMed ID: 26372217
[TBL] [Abstract][Full Text] [Related]
13. New insights into the genetic diversity of Leishmania RNA Virus 1 and its species-specific relationship with Leishmania parasites.
Cantanhêde LM; Fernandes FG; Ferreira GEM; Porrozzi R; Ferreira RGM; Cupolillo E
PLoS One; 2018; 13(6):e0198727. PubMed ID: 29912912
[TBL] [Abstract][Full Text] [Related]
14. Transcriptomics analysis highlights potential ways in human pathogenesis in Leishmania braziliensis infected with the viral endosymbiont LRV1.
Felipin KP; Paloschi MV; Silva MDS; Ikenohuchi YJ; Santana HM; Setúbal SDS; Rego CMA; Lopes JA; Boeno CN; Serrath SN; De Medeiros EHRT; Pimentel IF; Oliveira AER; Cupolillo E; Cantanhêde LM; Ferreira RGM; Zuliani JP
PLoS Negl Trop Dis; 2024 May; 18(5):e0012126. PubMed ID: 38743668
[TBL] [Abstract][Full Text] [Related]
15. Association of the Endobiont Double-Stranded RNA Virus LRV1 With Treatment Failure for Human Leishmaniasis Caused by Leishmania braziliensis in Peru and Bolivia.
Adaui V; Lye LF; Akopyants NS; Zimic M; Llanos-Cuentas A; Garcia L; Maes I; De Doncker S; Dobson DE; Arevalo J; Dujardin JC; Beverley SM
J Infect Dis; 2016 Jan; 213(1):112-21. PubMed ID: 26123565
[TBL] [Abstract][Full Text] [Related]
16. In situ study of cellular immune response in human cutaneous lesions caused by Leishmania (Viannia) panamensis in Panama.
Gonzalez K; Calzada JE; Tomokane TY; Pacheco CMS; Flores GVA; Castro Gomes CM; Pereira Corbett CE; Saldaña A; Laurenti MD
Parasite Immunol; 2021 Mar; 43(3):e12801. PubMed ID: 33068443
[TBL] [Abstract][Full Text] [Related]
17. Raising the suspicion of a non-autochthonous infection: identification of Leishmania guyanensis from Costa Rica exhibits a Leishmaniavirus related to Brazilian north-east and French Guiana viral genotypes.
Mata-Somarribas C; Quesada-López J; Matamoros MF; Cervantes-Gómez C; Mejía A; Chacón K; Bendig I; Campos R; Quesada-Morera R; Cantanhêde LM; Pereira LOR; Cupolillo E
Mem Inst Oswaldo Cruz; 2023; 117():e220162. PubMed ID: 36651455
[TBL] [Abstract][Full Text] [Related]
18. Exploitation of the Leishmania exosomal pathway by Leishmania RNA virus 1.
Atayde VD; da Silva Lira Filho A; Chaparro V; Zimmermann A; Martel C; Jaramillo M; Olivier M
Nat Microbiol; 2019 Apr; 4(4):714-723. PubMed ID: 30692670
[TBL] [Abstract][Full Text] [Related]
19. Capsid Structure of
Procházková M; Füzik T; Grybchuk D; Falginella FL; Podešvová L; Yurchenko V; Vácha R; Plevka P
J Virol; 2021 Jan; 95(3):. PubMed ID: 33208443
[No Abstract] [Full Text] [Related]
20. Unraveling the genetic diversity and phylogeny of Leishmania RNA virus 1 strains of infected Leishmania isolates circulating in French Guiana.
Tirera S; Ginouves M; Donato D; Caballero IS; Bouchier C; Lavergne A; Bourreau E; Mosnier E; Vantilcke V; Couppié P; Prevot G; Lacoste V
PLoS Negl Trop Dis; 2017 Jul; 11(7):e0005764. PubMed ID: 28715422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
